indazoles has been researched along with Soft Tissue Neoplasms in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.44) | 29.6817 |
| 2010's | 24 (58.54) | 24.3611 |
| 2020's | 16 (39.02) | 2.80 |
| Authors | Studies |
|---|---|
| Caldari, E; De Paolis, M; Fiore, M; Giannini, C; Pirini, MG; Sambri, A; Spinnato, P; Zucchini, R | 1 |
| Ahrens, M; Andresen, C; Apostolidis, L; Aybey, B; Bauer, S; Beck, K; Bitzer, M; Boerries, M; Brandts, CH; Brors, B; Egerer, G; Folprecht, G; Fröhling, S; Glimm, H; Hamacher, R; Heilig, CE; Heining, C; Hohenberger, P; Horak, P; Hübschmann, D; Illert, AL; Jost, PJ; Keilholz, U; Kindler, T; Klauschen, F; Köhler, BC; Kreutzfeldt, S; Laßmann, A; Lipka, DB; Mechtersheimer, G; Mock, A; Möhrmann, L; Mughal, SS; Pirmann, S; Renner, M; Richter, D; Richter, S; Schlenk, RF; Schröck, E; Schulze-Osthoff, K; Siveke, JT; Stenzinger, A; Teleanu, V; von Bubnoff, N; Weichert, W; Westphalen, CB; Winter, U | 1 |
| Bauer, S; Chemnitz, JM; Crysandt, M; Egerer, G; Grünwald, V; Hamacher, R; Hentschel, L; Ivanyi, P; Kasper, B; Kopp, HG; Kunitz, A; Lindner, L; Liu, X; Richter, S; Schöffski, P; Schuler, MK; Steffen, B; Stein, A | 1 |
| Aoyama, T; Azuma, K; Furutani, R; Hama, T; Hashimoto, K; Hiraide, M; Ito, K; Kobayashi, K; Nakano, K; Okawa, T; Sato, H; Sugiyama, E; Suzuki, K; Tajima, M; Takahashi, S; Tomomatsu, J; Yuasa, T | 1 |
| Acar, R; Akgul, F; Artac, M; Aydin, SG; Bahceci, A; Besiroglu, M; Bilici, A; Cinkir, HY; Dal, P; Demir, H; Demiray, AG; Derin, S; Eraslan, E; Erdem, D; Ergun, Y; Erol, C; Goksu, SS; Guc, ZG; Gumusay, O; Gunaydin, UM; Kaplan, MA; Karaagac, M; Karaca, M; Koca, S; Koral, L; Menekse, S; Ocak, B; Ozkul, O; Ozveren, A; Ozyukseler, DT; Paydas, S; Sahin, S; Sakalar, T; Sakin, A; Seker, MM; Sunar, V; Turhal, S; Unal, OU; Yekeduz, E | 1 |
| Esser, M; Gast, GC; Horger, M; Kloth, C; Kraus, MS; Reinert, CP; Thaiss, WM | 1 |
| Belgioia, L; Bertulli, R; Buscaglia, M; Catalano, F; Comandini, D; Grassi, M; Rebuzzi, SE; Satragno, C | 1 |
| Bertucci, F; Blay, JY; Bompas, E; Brodowicz, T; Chaigneau, L; Chevreau, C; Decoupigny, E; Delcambre, C; Italiano, A; Laroche, L; Le Cesne, A; Le Deley, MC; Mir, O; Penel, N; Ray-Coquard, I; Saada-Bouzid, E; Salas, S; Taieb, S; Vanseymortier, M; Wallet, J | 1 |
| Aydın, D; Beşiroğlu, M; Bilici, M; Dane, F; Doğu, GG; Hacıoğlu, B; Kaplan, NB; Karaca, M; Koca, S; Oruç, Z; Özçelik, M | 1 |
| Levin, AS | 1 |
| Agulnik, M; Attia, S; Eulo, V; Haarberg, S; Hirbe, AC; Kershner, T; Luo, J; Milhem, M; Monga, V; Moon, CI; Myles, S; Okuno, S; Parkes, A; Robinson, S; Seetharam, M; Toeniskoetter, J; Van Tine, BA | 1 |
| Bari, A; Caputo, F; Cerma, K; Dominici, M; Fanelli, M; Gelsomino, F; Pozzi, S | 1 |
| Itoh, H; Iwasaki, T; Kawano, M; Matsumoto, A; Shiraiwa, K; Suzuki, Y; Tanaka, K; Tanaka, R; Tatsuta, R; Tsumura, H | 1 |
| Asanuma, K; Hagi, T; Nakamura, T; Sudo, A | 1 |
| Fukasawa, N; Nomura, S; Teshima, Y | 1 |
| Bakhshi, S; Biswas, B; Kataria, B; Pushpam, D; Sharma, A | 1 |
| Aiba, H; Hayashi, K; Kawaguchi, Y; Kimura, H; Miwa, S; Murakami, H; Nakanishi, R; Okamoto, H; Saito, S; Sakai, T; Tatematsu, T; Yamada, S | 1 |
| Desar, IME; Kaal, SEJ; Soomers, VLMN; van der Graaf, WTA; van Erp, NP; Verwiel, J | 1 |
| Alavi, SN; Florou, V; Tinoco, G; Trent, JC; Wilky, BA | 1 |
| Baich, TM; Derbala, MH; Guo, AS; Ho, TH; Justice, CN; Kempton, AN; Smith, SA | 1 |
| Ahn, JB; Choi, YD; Chung, HC; Han, JW; Heo, SJ; Hur, H; Kim, HS; Kim, JH; Kim, KS; Kim, S; Kim, SH; Kim, SK; Lee, YH; Noh, SH; Park, HS; Rha, SY; Shin, KH; Suh, JS | 1 |
| Groenland, SL; Huitema, ADR; Katz, D; Steeghs, N | 1 |
| Bernabeu, D; Biscuola, M; Blay, JY; Casali, PG; Collini, P; Cruz, J; de Alava, E; Dei Tos, AP; Diaz-Martin, J; Dopazo, J; Dumont, S; Garcia Del Muro, X; Grignani, G; Gutierrez, A; Hindi, N; Italiano, A; LeCesne, A; Lopez-Pousa, A; Martin-Broto, J; Martinez-Trufero, J; Moura, DS; Palmerini, E; Peña-Chilet, M; Ranchere-Vince, D; Redondo, A; Sebio, A; Stacchiotti, S; Taron, M | 1 |
| Hayashi, K; Igarashi, K; Miwa, S; Takeuchi, A; Tsuchiya, H; Yamamoto, N | 1 |
| Trent, JC; Van Tine, BA | 1 |
| Hohenberger, P; Ronellenfitsch, U | 1 |
| Araki, N | 1 |
| Bernabeu, D; Blay, JY; Brenca, M; Brich, S; Casali, PG; Castelli, C; Collini, P; Cruz, J; Dagrada, GP; de Alava, E; Dumont, S; Ferrari, S; Frezza, AM; Grignani, G; Gutierrez, A; Hindi, N; Italiano, A; Karanian, M; LeCesne, A; Lopez-Pousa, A; Maestro, R; Martin-Broto, J; Morosi, C; Palmerini, E; Penel, N; Racanelli, D; Redondo, A; Stacchiotti, S; Vallacchi, V; Vaz Salgado, MA | 1 |
| Ae, K; Gokita, T; Inagaki, L; Matsumoto, S; Motoi, N; Nakano, K; Shimoji, T; Takahashi, S; Tanizawa, T; Tomomatsu, J | 1 |
| Araki, N; Hamada, K; Imura, Y; Itoh, K; Naka, N; Outani, H; Tanaka, T; Wakamatsu, T; Yoshikawa, H | 1 |
| Aihara, M; Fujita, H; Oda, K; Sato, M; Wada, H | 1 |
| Borst, G; de Pree, I; Dewit, L; Gelderblom, H; Haas, RL; Hartgrink, HH; Kerst, JM; Nout, RA; Scholten, A; Sleijfer, S; Steeghs, N; van Boven, HH; van Coevorden, F; van der Hage, J; Verhoef, C | 1 |
| Bouvet, M; Chishima, T; Endo, I; Hiroshima, Y; Hoffman, RM; Ichikawa, Y; Maawy, A; Matsuyama, R; Mii, S; Miwa, S; Momiyama, M; Mori, R; Murakami, T; Tanaka, K; Uehara, F; Yamamoto, M; Yano, S; Zhang, N; Zhang, Y; Zhao, M | 1 |
| Grünwald, V; Karch, A; Koch, A | 1 |
| de Waal, YR; Leenders, W; Ottevanger, PB; Tops, B; van der Steen, MJ; Westermann, A | 1 |
| Blay, JY; Collin, F; De Brauwer, A; Le Cesne, A; Marreaud, S; Pandite, L; Papai, Z; Ray-Coquard, I; Schöffski, P; Scurr, M; Sleijfer, S; van Glabbeke, M; Verweij, J | 1 |
| Deville, JL; Duffaud, F; Huynh, T; Salas, S | 1 |
| Bramwell, VH | 1 |
| Aglietta, M; Araki, N; Beppu, Y; Blay, JY; Bui-Nguyen, B; Casali, PG; Chawla, SP; Coens, C; Dei Tos, AP; Demetri, GD; Dewji, MR; Fletcher, CD; Gelderblom, H; Hodge, R; Hohenberger, P; Judson, IR; Kim, DW; Le Cesne, A; Marreaud, S; Ouali, M; Schöffski, P; Staddon, AP; van der Graaf, WT | 1 |
| Issels, RD; Lindner, LH | 1 |
| Arai, H; Fukasawa, N; Ueta, F | 1 |
8 review(s) available for indazoles and Soft Tissue Neoplasms
| Article | Year |
|---|---|
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives.
Topics: Anthracyclines; Antineoplastic Agents; Chemotherapy, Adjuvant; Epigenomics; Gene Expression Regulation, Neoplastic; Genomics; Humans; Ifosfamide; Indazoles; Molecular Targeted Therapy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Soft Tissue Neoplasms; Sulfonamides; Surgical Procedures, Operative; Trabectedin | 2021 |
Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: A case report and review of the literature.
Topics: Angiogenesis Inhibitors; Fibroma; Fibrosarcoma; Humans; Indazoles; Male; Middle Aged; Polycythemia; Protein Kinase Inhibitors; Pyrimidines; Soft Tissue Neoplasms; Sulfonamides | 2021 |
A precision medicine approach in sarcoma: identification of patients who may benefit from early use of pazopanib.
Topics: Humans; Indazoles; Precision Medicine; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2018 |
The Impact of Pazopanib on the Cardiovascular System.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Renal Cell; Cardiovascular Diseases; Cardiovascular System; Humans; Indazoles; Kidney Neoplasms; Pyrimidines; Risk Assessment; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Treatment Outcome | 2018 |
Therapeutic Targets for Bone and Soft-Tissue Sarcomas.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Neoplasms; Drug Therapy; Furans; Humans; Immunotherapy, Adoptive; Indazoles; Ipilimumab; Ketones; Nivolumab; Osteosarcoma; Progression-Free Survival; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sorafenib; Sulfonamides; Trabectedin | 2019 |
[Antiangionic drugs in soft tissue sarcoma].
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Doxorubicin; Humans; Indazoles; Indoles; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pyridines; Pyrimidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sarcoma; Soft Tissue Neoplasms; Sorafenib; Sulfonamides; Sunitinib; Vascular Endothelial Growth Factor A | 2010 |
[Soft-tissue sarcoma: recent developments].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dacarbazine; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Gemcitabine; Humans; Hyperthermia, Induced; Indazoles; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Sirolimus; Soft Tissue Neoplasms; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Pharmacological profile and clinical results in advanced soft tissue sarcoma patients of pazopanib hydrochloride (Votrient(®))].
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Indazoles; Mice; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Treatment Outcome | 2013 |
9 trial(s) available for indazoles and Soft Tissue Neoplasms
| Article | Year |
|---|---|
A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome.
Topics: Activities of Daily Living; Aged; Doxorubicin; Humans; Indazoles; Sarcoma; Soft Tissue Neoplasms | 2023 |
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Chest Pain; Cross-Over Studies; Diarrhea; Disease Progression; Double-Blind Method; Female; Humans; Indazoles; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Phenylurea Compounds; Pyridines; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Treatment Outcome | 2020 |
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy.
Topics: Aged; Female; Humans; Indazoles; Male; Neoplasm Metastasis; Progression-Free Survival; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2020 |
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Female; Humans; Indazoles; Male; Middle Aged; Multivariate Analysis; Pyrimidines; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms; Solitary Fibrous Tumors; Sulfonamides; Survival Analysis | 2019 |
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chondrosarcoma; Disease-Free Survival; Female; Humans; Indazoles; Male; Middle Aged; Neoplasm Staging; Neoplasms, Connective and Soft Tissue; Pyrimidines; Retrospective Studies; Soft Tissue Neoplasms; Sulfonamides; Treatment Outcome | 2019 |
A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities.
Topics: Adult; Aged; Angiogenesis Inhibitors; Chemoradiotherapy, Adjuvant; Extremities; Female; Humans; Indazoles; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Young Adult | 2015 |
A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial.
Topics: Age Factors; Aged; Antibiotics, Antineoplastic; Belgium; Clinical Protocols; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Geriatric Assessment; Germany; Humans; Indazoles; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Protein Kinase Inhibitors; Pyrimidines; Quality of Life; Research Design; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Time Factors; Treatment Outcome | 2016 |
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 620
Topics: Adult; Aged; Angiogenesis Inhibitors; Disease-Free Survival; Female; Humans; Indazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2009 |
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cross-Over Studies; Disease-Free Survival; Double-Blind Method; Female; Humans; Indazoles; Kaplan-Meier Estimate; Male; Middle Aged; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Treatment Outcome; Young Adult | 2012 |
24 other study(ies) available for indazoles and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Gene expression-based prediction of pazopanib efficacy in sarcoma.
Topics: Gene Expression; Humans; Indazoles; Prospective Studies; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Young Adult | 2022 |
Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma.
Topics: Angiogenesis Inhibitors; Carcinoma, Renal Cell; East Asian People; Humans; Indazoles; Kidney Neoplasms; Sarcoma; Soft Tissue Neoplasms | 2023 |
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Topics: Adult; Female; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Neoplasms, Second Primary; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Turkey | 2023 |
CT-morphologic and CT-textural patterns of response in inoperable soft tissue sarcomas treated with pazopanib-a preliminary retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Indazoles; Male; Middle Aged; Pyrimidines; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Multiple systemic treatment options in a patient with malignant tenosynovial giant cell tumour.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Giant Cell Tumor of Tendon Sheath; Humans; Imatinib Mesylate; Indazoles; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2020 |
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study.
Topics: Adult; Female; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Progression-Free Survival; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Survival Analysis | 2021 |
CORR Insights®: Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
Topics: Biomarkers; Humans; Indazoles; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2020 |
Development of a High-Throughput Quantification Method for Pazopanib Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Clinical Application in Patients With Soft Tissue Tumors.
Topics: Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Indazoles; Pyrimidines; Reproducibility of Results; Soft Tissue Neoplasms; Sulfonamides; Tandem Mass Spectrometry | 2021 |
Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Female; Furans; Humans; Indazoles; Japan; Kaplan-Meier Estimate; Ketones; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Pyrimidines; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Survival Analysis; Trabectedin; Treatment Outcome | 2020 |
Postmarketing observational study of pazopanib in patients with metastatic soft tissue sarcoma in Japan.
Topics: Adolescent; Adult; Aged; Female; Humans; Incidence; Indazoles; Japan; Male; Middle Aged; Product Surveillance, Postmarketing; Progression-Free Survival; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Treatment Outcome; Young Adult | 2021 |
Oral metronomic chemotherapy is a cost effective alternative to pazopanib in advanced soft tissue sarcoma.
Topics: Cost-Benefit Analysis; Humans; Indazoles; Pyrimidines; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2022 |
Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Incidence; Indazoles; Lung; Lung Neoplasms; Male; Middle Aged; Pleura; Pneumothorax; Pyrimidines; Retrospective Studies; Risk Assessment; Risk Factors; Soft Tissue Neoplasms; Sulfonamides; Time Factors | 2021 |
Fatal heart failure in a young adult female sarcoma patient treated with pazopanib.
Topics: Adult; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Heart Failure; Humans; Indazoles; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2017 |
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Indazoles; Male; Middle Aged; Pyrimidines; Retrospective Studies; Soft Tissue Neoplasms; Sulfonamides; Young Adult | 2019 |
Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levels.
Topics: Aged; Angiogenesis Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Soft Tissue Neoplasms; Sulfonamides | 2018 |
How we use pazopanib in treating soft-tissue sarcoma: experience at our multidisciplinary sarcoma centers.
Topics: Deoxycytidine; Gemcitabine; Humans; Indazoles; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2019 |
ASO Author Reflections: Preoperative Pazopanib for High-Risk Soft Tissue Sarcoma: Better Patient Selection is Needed.
Topics: Humans; Indazoles; Patient Selection; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2019 |
Fusion gene-oriented precision medicine in soft tissue sarcoma.
Topics: Chondrosarcoma; Humans; Indazoles; Precision Medicine; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2019 |
Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.
Topics: Adult; Angiogenesis Inhibitors; Humans; Incidence; Indazoles; Male; Middle Aged; Pneumothorax; Pyrimidines; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2014 |
Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.
Topics: Adult; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Chromosome Breakpoints; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Indazoles; Mice; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-met; Pyrimidines; Sarcoma, Clear Cell; Signal Transduction; Soft Tissue Neoplasms; Sulfonamides; Transcription Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Pazopanib-induced leg ulcer in a patient with malignant fibrous histiocytoma.
Topics: Aged, 80 and over; Female; Histiocytoma, Malignant Fibrous; Humans; Indazoles; Leg Ulcer; Protein-Tyrosine Kinases; Pyrimidines; Soft Tissue Neoplasms; Sulfonamides | 2014 |
Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice.
Topics: Animals; Antineoplastic Agents; Deoxycytidine; Disease Models, Animal; Gemcitabine; Indazoles; Mice; Mice, Nude; Pyrimidines; Salmonella Infections; Salmonella typhimurium; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Xenograft Model Antitumor Assays | 2015 |
An impressive response to pazopanib in a patient with metastatic endometrial carcinoma.
Topics: Abdominal Wall; Angiogenesis Inhibitors; Carcinoma, Endometrioid; Chemoradiotherapy, Adjuvant; Endometrial Neoplasms; Female; Humans; Hysterectomy; Indazoles; Intestinal Fistula; Middle Aged; Neoplasm Metastasis; Ovariectomy; Pyrimidines; Remission Induction; Salpingectomy; Soft Tissue Neoplasms; Sulfonamides | 2016 |
Pazopanib and the treatment palette for soft-tissue sarcoma.
Topics: Antineoplastic Agents; Female; Humans; Indazoles; Male; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sulfonamides | 2012 |